Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
52
JHX Quote, Financials, Valuation and Earnings
Last price:
$25.99
Seasonality move
:
1.42%
Day range:
$25.68 - $27.43
52-week range:
$16.46 - $33.00
Dividend yield:
0%
P/E ratio:
97.60x
P/S ratio:
2.99x
P/B ratio:
2.35x
Volume:
15M
Avg. volume:
6.8M
1-year change:
-21.99%
Market cap:
$15.1B
Revenue:
$3.9B
EPS (TTM):
$0.27
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3.6B | $3.8B | $3.9B | $3.9B | |
| Revenue Growth (YoY) | 11.58% | 24.27% | 4.49% | 4.22% | -1.49% | |
| Cost of Revenues | $1.9B | $2.3B | $2.5B | $2.3B | $2.4B | |
| Gross Profit | $1.1B | $1.3B | $1.3B | $1.6B | $1.5B | |
| Gross Profit Margin | 36.16% | 36.34% | 34.74% | 40.35% | 38.81% | |
| R&D Expenses | $34.3M | $38M | $39.6M | $47M | $48.5M | |
| Selling, General & Admin | -- | -- | -- | -- | $596.2M | |
| Other Inc / (Exp) | -$168M | -$131.9M | -$24.2M | -$169.1M | -$204.6M | |
| Operating Expenses | $416.8M | $500M | $530.9M | $649.3M | $645.3M | |
| Operating Income | $634.9M | $813.5M | $781.1M | $939.1M | $859.7M | |
| Net Interest Expenses | $48.5M | $40.3M | $37M | $36.4M | $41M | |
| EBT. Incl. Unusual Items | $412M | $643.1M | $723.5M | $754.8M | $645.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $149.2M | $184M | $211.5M | $244.6M | $221.4M | |
| Net Income to Company | $262.8M | $459.1M | $512M | $510.2M | $424M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $262.8M | $459.1M | $512M | $510.2M | $424M | |
| Basic EPS (Cont. Ops) | $0.59 | $1.03 | $1.15 | $1.16 | $0.98 | |
| Diluted EPS (Cont. Ops) | $0.59 | $1.03 | $1.15 | $1.16 | $0.98 | |
| Weighted Average Basic Share | $443.7M | $444.9M | $445.1M | $438.4M | $430.8M | |
| Weighted Average Diluted Share | $445.4M | $445.9M | $445.6M | $439.6M | $432.1M | |
| EBITDA | $767.1M | $975.3M | $953.7M | $1.1B | $1.1B | |
| EBIT | $634.9M | $813.5M | $781.1M | $939.1M | $859.7M | |
| Revenue (Reported) | $2.9B | $3.6B | $3.8B | $3.9B | $3.9B | |
| Operating Income (Reported) | $634.9M | $813.5M | $781.1M | $939.1M | $859.7M | |
| Operating Income (Adjusted) | $634.9M | $813.5M | $781.1M | $939.1M | $859.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $900M | $860.8M | $978.3M | $953.3M | $1.2B | |
| Revenue Growth (YoY) | 21.85% | -4.36% | 13.65% | -2.56% | 30.05% | |
| Cost of Revenues | $577.5M | $571.2M | $577.6M | $590.9M | $791.6M | |
| Gross Profit | $322.5M | $289.6M | $400.7M | $362.4M | $448.2M | |
| Gross Profit Margin | 35.83% | 33.64% | 40.96% | 38.02% | 36.15% | |
| R&D Expenses | $9.7M | $9.4M | $10.7M | $11.5M | $16.6M | |
| Selling, General & Admin | -- | -- | -- | $144.7M | -- | |
| Other Inc / (Exp) | -$1.6M | -$2.1M | -$7M | -$100K | -- | |
| Operating Expenses | $119.1M | $123.7M | $166.1M | $156.3M | $266.6M | |
| Operating Income | $203.4M | $165.9M | $234.6M | $206.1M | $181.6M | |
| Net Interest Expenses | $10.8M | $9.1M | $9.4M | $11.2M | $65.6M | |
| EBT. Incl. Unusual Items | $191.6M | $156M | $223.6M | $202.3M | $110.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $56.2M | $55.9M | $78.5M | $60.6M | $41.9M | |
| Net Income to Company | $126.8M | $102M | $142.2M | $134.4M | $69.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $135.4M | $100.1M | $145.1M | $141.7M | $68.7M | |
| Basic EPS (Cont. Ops) | $0.30 | $0.22 | $0.33 | $0.33 | $0.12 | |
| Diluted EPS (Cont. Ops) | $0.30 | $0.22 | $0.33 | $0.33 | $0.12 | |
| Weighted Average Basic Share | $445.2M | $445.4M | $437M | $429.5M | $579.4M | |
| Weighted Average Diluted Share | $446.3M | $445.9M | $438.3M | $430.9M | $583.1M | |
| EBITDA | $244.6M | $209.4M | $280.9M | $261.2M | $329.2M | |
| EBIT | $203.4M | $165.9M | $234.6M | $206.1M | $181.6M | |
| Revenue (Reported) | $900M | $860.8M | $978.3M | $953.3M | $1.2B | |
| Operating Income (Reported) | $203.4M | $165.9M | $234.6M | $206.1M | $181.6M | |
| Operating Income (Adjusted) | $203.4M | $165.9M | $234.6M | $206.1M | $181.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.5B | $3.8B | $3.8B | $3.9B | $4.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.2B | $2.5B | $2.3B | $2.4B | $2.8B | |
| Gross Profit | $1.3B | $1.3B | $1.5B | $1.5B | $1.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $36.6M | $39.9M | $42.7M | $50.6M | $56.9M | |
| Selling, General & Admin | -- | -- | -- | $294.6M | $558.7M | |
| Other Inc / (Exp) | -$30.4M | -$110.3M | -$77.7M | -$206.2M | -- | |
| Operating Expenses | $488.2M | $519.8M | $612.7M | $660.5M | $1B | |
| Operating Income | $762M | $816.5M | $895M | $882.4M | $575.5M | |
| Net Interest Expenses | $40.6M | $36.5M | $36.3M | $31.5M | $182.4M | |
| EBT. Incl. Unusual Items | $692.1M | $673M | $797.1M | $668.6M | $219.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $187.2M | $190.2M | $261.1M | $232.6M | $100M | |
| Net Income to Company | $495.8M | $471.8M | $556.2M | $434.6M | $116.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $504.9M | $482.8M | $536M | $436M | $119.1M | |
| Basic EPS (Cont. Ops) | $1.14 | $1.08 | $1.22 | $1.01 | $0.27 | |
| Diluted EPS (Cont. Ops) | $1.13 | $1.08 | $1.22 | $1.01 | $0.27 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $919.4M | $985.4M | $1.1B | $1.1B | $965.4M | |
| EBIT | $762M | $816.5M | $895M | $882.4M | $575.5M | |
| Revenue (Reported) | $3.5B | $3.8B | $3.8B | $3.9B | $4.4B | |
| Operating Income (Reported) | $762M | $816.5M | $895M | $882.4M | $575.5M | |
| Operating Income (Adjusted) | $762M | $816.5M | $895M | $882.4M | $575.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.9B | $2.9B | $2.9B | $3.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.7B | $1.9B | $1.8B | $1.8B | $2.2B | |
| Gross Profit | $959.2M | $982M | $1.2B | $1.1B | $1.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $27.5M | $29.4M | $32.5M | $36.1M | $44.5M | |
| Selling, General & Admin | -- | -- | -- | $294.6M | $406.9M | |
| Other Inc / (Exp) | $10.7M | $32.3M | -$21.6M | -$58.1M | -- | |
| Operating Expenses | $370.2M | $392.1M | $469.9M | $481.1M | $702.3M | |
| Operating Income | $589M | $589.9M | $707.8M | $651.1M | $503.9M | |
| Net Interest Expenses | $31.4M | $27.6M | $26.9M | $22M | $171.2M | |
| EBT. Incl. Unusual Items | $569.3M | $599.2M | $672.8M | $586.6M | $160.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $162.4M | $168.6M | $218.2M | $206.2M | $84.8M | |
| Net Income to Company | $395.3M | $423.7M | $451.6M | $375.5M | $76.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $406.9M | $430.6M | $454.6M | $380.4M | $75.5M | |
| Basic EPS (Cont. Ops) | $0.91 | $0.97 | $1.03 | $0.88 | $0.17 | |
| Diluted EPS (Cont. Ops) | $0.91 | $0.97 | $1.03 | $0.88 | $0.17 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.6B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.6B | |
| EBITDA | $708.5M | $716.5M | $844.5M | $807.9M | $834.4M | |
| EBIT | $589M | $589.9M | $707.8M | $651.1M | $503.9M | |
| Revenue (Reported) | $2.6B | $2.9B | $2.9B | $2.9B | $3.4B | |
| Operating Income (Reported) | $589M | $589.9M | $707.8M | $651.1M | $503.9M | |
| Operating Income (Adjusted) | $589M | $589.9M | $707.8M | $651.1M | $503.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $345M | $391.6M | $326.5M | $594.2M | $781.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $290.6M | $333M | $298.6M | $312.7M | $328.9M | |
| Inventory | $218.3M | $279.7M | $344.2M | $337.8M | $347.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $40.5M | $46.4M | $42.8M | $69.8M | $102.9M | |
| Total Current Assets | $943.6M | $1.1B | $1.1B | $1.4B | $1.7B | |
| Property Plant And Equipment | $1.4B | $1.5B | $1.9B | $2.1B | $2.2B | |
| Long-Term Investments | $42.9M | $37.8M | $64.4M | $26.4M | $23.2M | |
| Goodwill | $209.3M | $199.5M | $194.9M | $192.6M | $193.7M | |
| Other Intangibles | $173.9M | $162.8M | $155.2M | $149.2M | $145.6M | |
| Other Long-Term Assets | $3.4M | $4.1M | $56.1M | $19.3M | $24.8M | |
| Total Assets | $4.1B | $4.2B | $4.5B | $4.9B | $5.2B | |
| Accounts Payable | $174M | $273.6M | $198.2M | $252M | $232.5M | |
| Accrued Expenses | $203M | $254.1M | $244.6M | $286.4M | $280.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $7.5M | $9.4M | |
| Current Portion Of Capital Lease Obligations | $8.8M | $13.6M | $18.1M | $19M | $21.6M | |
| Other Current Liabilities | $154.9M | $162.3M | $160.6M | $142.7M | $179.6M | |
| Total Current Liabilities | $901.1M | $769.9M | $697.3M | $797.7M | $810.2M | |
| Long-Term Debt | $913.8M | $941.9M | $1.1B | $1.2B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3B | $2.9B | $2.9B | $3.1B | $3.1B | |
| Common Stock | $231.4M | $232.1M | $230M | $224.7M | $222.1M | |
| Other Common Equity Adj | -$6.6M | -$22M | -$53.3M | -$68.3M | -$58.2M | |
| Common Equity | $1.1B | $1.3B | $1.6B | $1.9B | $2.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.1B | $1.3B | $1.6B | $1.9B | $2.2B | |
| Total Liabilities and Equity | $4.1B | $4.2B | $4.5B | $4.9B | $5.2B | |
| Cash and Short Terms | $345M | $391.6M | $326.5M | $594.2M | $781.4M | |
| Total Debt | $914.8M | $943M | $1.1B | $1.2B | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $297.4M | $265.4M | $645.3M | $731.6M | $562.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $325.6M | $286.2M | $311.6M | $270.6M | $311M | |
| Inventory | $270.1M | $371.4M | $321.4M | $350.3M | $665.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $39.2M | $70.6M | $70.6M | $72M | -- | |
| Total Current Assets | $938.6M | $1B | $1.4B | $1.5B | $1.7B | |
| Property Plant And Equipment | $1.5B | $1.8B | $2B | $2.2B | $3.3B | |
| Long-Term Investments | $34.5M | $86.8M | $41.2M | $35.3M | $21.5M | |
| Goodwill | $202.2M | $190.3M | $197.8M | $186M | -- | |
| Other Intangibles | $165.8M | $152.7M | $154.1M | $141.1M | -- | |
| Other Long-Term Assets | $3.3M | $64.4M | $21.1M | $22.7M | -- | |
| Total Assets | $4B | $4.3B | $4.8B | $4.9B | $13.8B | |
| Accounts Payable | $389.2M | $396.5M | $440M | $391.1M | $667.2M | |
| Accrued Expenses | $101.4M | $96.4M | $128.8M | $115.2M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $7.5M | $7.5M | -- | |
| Current Portion Of Capital Lease Obligations | $10.3M | $18.7M | $20.5M | $20.7M | -- | |
| Other Current Liabilities | $169.9M | $145.4M | $138.2M | $145.8M | -- | |
| Total Current Liabilities | $688.5M | $675.5M | $749.1M | $684.5M | $1.1B | |
| Long-Term Debt | $959.2M | $1B | $1.2B | $1.2B | $4.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.7B | $2.7B | $2.9B | $2.8B | $7.4B | |
| Common Stock | $232.1M | $231.4M | $225.9M | $222.1M | $326.4M | |
| Other Common Equity Adj | -$26.2M | -$56.6M | -$43.7M | -$69.6M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.3B | $1.6B | $1.9B | $2.1B | $6.4B | |
| Total Liabilities and Equity | $4B | $4.3B | $4.8B | $4.9B | $13.8B | |
| Cash and Short Terms | $297.4M | $265.4M | $645.3M | $731.6M | $562.2M | |
| Total Debt | $960.2M | $1.1B | $1.2B | $1.2B | $4.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $262.8M | $459.1M | $512M | $510.2M | $424M | |
| Depreciation & Amoritzation | $135M | $161.8M | $172.6M | $185M | $216.2M | |
| Stock-Based Compensation | $18M | $9M | $15.7M | $28.2M | $23M | |
| Change in Accounts Receivable | $52.2M | -$62.6M | $38.3M | -$14.1M | -$25M | |
| Change in Inventories | $98.7M | -$64.3M | -$70.8M | $3.4M | -$15.7M | |
| Cash From Operations | $777.4M | $755.3M | $599.1M | $894.7M | $781.8M | |
| Capital Expenditures | $110.7M | $257.8M | $591.3M | $449.3M | $422.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$110.9M | -$346.3M | -$651.6M | -$451M | -$425.7M | |
| Dividends Paid (Ex Special Dividend) | -- | $484M | $129.6M | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $390M | $450M | $395M | -- | |
| Long-Term Debt Repaid | -$530.8M | -$351M | -$261.5M | -$328M | -$8.7M | |
| Repurchase of Common Stock | -- | -- | $78.4M | $271.4M | $149.9M | |
| Other Financing Activities | -$9.5M | -$4.9M | -$6.1M | -$6.1M | -$7.3M | |
| Cash From Financing | -$540.2M | -$449.6M | -$25.4M | -$210.1M | -$165.9M | |
| Beginning Cash (CF) | $318.4M | $271.9M | $185.6M | $415.8M | $605.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $132.6M | -$46.5M | -$86.3M | $230.2M | $189.8M | |
| Ending Cash (CF) | $457.3M | $219.5M | $90.9M | $642.6M | $795M | |
| Levered Free Cash Flow | $666.7M | $497.5M | $7.8M | $445.4M | $359.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $126.8M | $102M | $142.2M | $134.4M | $69.2M | |
| Depreciation & Amoritzation | $38.7M | $43.7M | $45.4M | $52.1M | $147.3M | |
| Stock-Based Compensation | $2M | $3.8M | $8.1M | $5M | $9.2M | |
| Change in Accounts Receivable | $7.6M | $68.7M | $54.9M | $63.1M | $50.3M | |
| Change in Inventories | -$30.3M | -$44.1M | -$18.5M | $11.4M | -$27M | |
| Cash From Operations | $183.6M | $165.6M | $280.4M | $277.4M | $199.7M | |
| Capital Expenditures | $62.6M | $141.6M | $93.5M | $101.3M | $106.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -$30.7M | |
| Cash From Investing | -$84.3M | -$142.2M | -$93.3M | -$101.2M | $33.6M | |
| Dividends Paid (Ex Special Dividend) | $142.2M | $1.4M | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $70M | $40M | $300M | -- | -- | |
| Long-Term Debt Repaid | -$20.3M | -$20.2M | -$140.3M | -$2.1M | -- | |
| Repurchase of Common Stock | -- | $30.7M | $73.7M | -$3.4M | -- | |
| Other Financing Activities | -$2.1M | -$1.7M | -$4.8M | -$5.1M | -- | |
| Cash From Financing | -$95.8M | -$13.1M | $80.8M | -$3.5M | -$445.7M | |
| Beginning Cash (CF) | $275.6M | $143.4M | $451M | $557.5M | $374.9M | |
| Foreign Exchange Rate Adjustment | $1.3M | $4.8M | $1.9M | -$2.6M | -$1.1M | |
| Additions / Reductions | $4.8M | $15M | $269.9M | $170.2M | -$213.6M | |
| Ending Cash (CF) | $281.7M | $163.2M | $722.8M | $725.1M | $160.2M | |
| Levered Free Cash Flow | $120.9M | $24M | $186.9M | $176.2M | $93.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $495.8M | $471.8M | $556.2M | $434.6M | $116.2M | |
| Depreciation & Amoritzation | $154.8M | $164.7M | $189.3M | $204.2M | $390.2M | |
| Stock-Based Compensation | $18.4M | $5.3M | $27.4M | $25.3M | $34.5M | |
| Change in Accounts Receivable | -$59.2M | $33.9M | -$19.4M | $30.9M | $42.2M | |
| Change in Inventories | -$45M | -$106.6M | $49M | -$41.2M | -$73.1M | |
| Cash From Operations | $640.3M | $616.7M | $928.7M | $796.7M | $586.6M | |
| Capital Expenditures | $204M | $522.9M | $492.7M | $452.4M | $390.3M | |
| Cash Acquisitions | -- | -- | -- | -- | $3.9B | |
| Cash From Investing | -$199.2M | -$673.9M | -$502M | -$449.1M | -$4.2B | |
| Dividends Paid (Ex Special Dividend) | $448.7M | $146.4M | $6.2M | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $320M | $340M | -- | -- | -- | |
| Long-Term Debt Repaid | -$671M | -$221M | -$446.5M | -$8.7M | -- | |
| Repurchase of Common Stock | -- | $30.7M | $245.2M | $224.6M | -$1M | |
| Other Financing Activities | -- | -$5.8M | -- | -$7.3M | -- | |
| Cash From Financing | -$825.5M | -$68.3M | -$121.5M | -$239.9M | $3.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$392.6M | -$129.8M | $301.1M | $106.7M | -$186.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $436.3M | $93.8M | $436M | $344.3M | $196.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $395.3M | $423.7M | $451.6M | $375.5M | $76.1M | |
| Depreciation & Amoritzation | $116.1M | $124.6M | $135.8M | $154.8M | $333M | |
| Stock-Based Compensation | $12.5M | $9.2M | $20.4M | $17.5M | $29.4M | |
| Change in Accounts Receivable | $7.8M | $102.1M | $43.2M | $88.3M | $155M | |
| Change in Inventories | -$53.2M | -$97.7M | $24.3M | -$20.2M | -$78M | |
| Cash From Operations | $533.7M | $420.8M | $731.4M | $632.5M | $452.7M | |
| Capital Expenditures | $169.5M | $443.4M | $326.1M | $328.7M | $305.1M | |
| Cash Acquisitions | -- | -- | -- | -- | $3.9B | |
| Cash From Investing | -$165.4M | -$504.7M | -$334.5M | -$332.1M | -$4.1B | |
| Dividends Paid (Ex Special Dividend) | $448.7M | $127.5M | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $320M | $270M | $395M | -- | -- | |
| Long-Term Debt Repaid | -$270.8M | -$140.8M | -$325.8M | -$6.5M | -- | |
| Repurchase of Common Stock | -- | $30.7M | $195M | $148M | -- | |
| Other Financing Activities | -$4.9M | -$5.8M | -$6.1M | -$7.3M | -- | |
| Cash From Financing | -$402.7M | -$36.7M | -$132M | -$161.6M | $3.5B | |
| Beginning Cash (CF) | $765.3M | $479.6M | $787.4M | $1.3B | $3.1B | |
| Foreign Exchange Rate Adjustment | -$7.2M | -$5.8M | -$1.2M | $1.1M | -$1.8M | |
| Additions / Reductions | -$41.6M | -$126.4M | $263.7M | $139.9M | -$232.5M | |
| Ending Cash (CF) | $716.5M | $347.4M | $1B | $1.5B | $2.8B | |
| Levered Free Cash Flow | $364.1M | -$22.6M | $405.3M | $303.8M | $147.6M | |
Related Companies
Get JHX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
JHX
Sector
P/E ratio
97.60x
--
PEG ratio
--
--
P/B ratio
2.35x
--
Price / LTM sales
2.99x
--
Growth Metrics
JHX
Sector
Revenue growth
30.05%
--
Earnings growth
-64.17%
--
Revenue (5-year growth)
8.27%
--
Earnings forecast
$0.22
--
Profitability
JHX
Sector
Profitability FY 2024
$1.5B
--
Return on invested capital
1.73%
--
Return on assets
1.33%
--
Return on equity
3.1%
--
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
May
19
Estimated Next Earnings Date
May
12
Balance Sheet
JHX
Sector
Total cash
$562.2M
--
Short term investments
--
--
Total assets
$5.2B
--
Long term debt
$4.8B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.48% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 5.71% over the past day.
Buy
73
AEHR alert for Feb 12
Aehr Test Systems [AEHR] is down 15.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
